Home > Analytics > LYKA LABS

LYKA LABS
Intrinsic Value | Fundamental Analysis

BOM : 500259     NSE : LYKALABS    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : NA
Sep 27,2022
Price(EOD): ₹ 124.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 357.89 Cr
Value of ₹ 1 Lac invested in LYKA LABS
on Sep 27,2017 (price: ₹ 46.25)

₹ 1 L

₹ 2.70 L

1W : -8.9% 1M : -17.3% 1Y : 43.4%
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
LYKA LABS -8.9% -17.3% 43.4%
SUN PHARMACEUTICAL INDUSTRIES -0.9% 2% 16.6%
DIVIS LABORATORIES 2.9% 2.5% -29.2%
DR REDDYS LABORATORIES 0.8% -1% -14.9%
CIPLA 3% 7.9% 10.1%
GLAND PHARMA -5% -13.5% -47.2%
PIRAMAL ENTERPRISES -8.3% -55.7% -68%
CADILA HEALTHCARE -1.6% -5.7% -37.2%
TORRENT PHARMACEUTICALS 2.2% -0.9% -2.4%

FUNDAMENTAL ANALYSIS OF LYKA LABS

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF LYKA LABS

 
Valuation Score
[As on : Sep 27,2022 ]

Ratio Consolidated
P/E
P/B
P/S
18.19
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 19.67 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

26.82
P/B Calculated based on Book Value of Rs 13.34 Cr
[Latest Year - Mar2022 - Consolidated Results ]

2.08
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 172.14 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF LYKA LABS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
1813%
305%
195%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF LYKA LABS



LYKA LABS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF LYKA LABS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
2.9
36.68
7.29
15.62
9.76
-6.3
-9.85
-2.13
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF LYKA LABS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF LYKA LABS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-21.86%
-50%
135.98%
104.72%
-44.39%
-78.92%
-96.43%
-96.37%
QtrlyTrend
-4
Latest Qtr: Jun2022
Quarterly Result Analysis →


LYKA LABS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about LYKA LABS


Is LYKA LABS good for long term investment?

As on Sep 27,2022, the Fundamentals of LYKA LABS look Poor and hence it may not be good for long term investment ! See Financial Performance of LYKA LABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is LYKA LABS UnderValued or OverValued?

As on Sep 27,2022, LYKA LABS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of LYKA LABS ?

As on Sep 27,2022, the Intrinsic Value of LYKA LABS is Rs. 30.82 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 6.52
Fair Value [Median EV / Sales Model] : Rs. 30.82
Fair Value [Median Price / Sales Model] : Rs. 42.29
Estimated Median Fair Value of LYKA LABS : Rs. 30.82

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is LYKA LABS trading at a Premium or Discount?

As on Sep 27,2022, LYKA LABS is trading at a Premium of 305% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].